cjc dac and ipamorelin CJC-1295 (NO DAC) + – Research Peptide CJC-1295 No DAC + Ipamorelin

[DOI] [PMC free article] [PubMed] [Google Scholar] 62.Kaplan S.A., McConnell J.D., Roehrborn C.G., Meehan A.G., Lee M.W., Noble W.R., Kusek J.W., Nyberg L.M., Medical Therapy of Prostatic Symptoms (MTOPS) Research Group Combination Therapy with Doxazosin and Finasteride for Benign Prostatic Hyperplasia in Patients with Lower Urinary Tract Symptoms and a Baseline Total Prostate Volume of 25 Ml or Greater

This non-receptor-based strategy avoids the complexities of nuclear receptor modulation and offers a safe adjunctive therapy, particularly in paediatric and metabolic disorders involving bilirubin overload

[DOI] [PubMed] [Google Scholar] 91

Other agents such as phytic acid (inositol hexaphosphate), 1,10-phenanthroline, and deferoxamine (desferrioxamine